| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $781K | +19.3% |
| SG&A Expense | $3.6M | +11.0% |
| Operating Income | -$7.5M | -11.2% |
| Pre-tax Income | -$8.8M | -27.7% |
| Income Tax | $0 | — |
| Net Income | -$8.8M | -27.7% |
| EPS (Basic) | -$12.93 | -2250.9% |
| EPS (Diluted) | -$12.93 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $494 | +260.6% |
| Current Assets | $834K | -49.8% |
| Total Assets | $4.4M | -28.0% |
| Current Liabilities | $4.0M | +76.1% |
| Total Liabilities | $4.0M | +76.1% |
| Stockholders' Equity | $420K | -89.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.5M | +5.2% |
| Capital Expenditures | $2K | -36.8% |
| Investing Cash Flow | -$1.0M | +46.6% |
| Financing Cash Flow | $4.7M | +133.9% |
| Free Cash Flow | -$4.5M | +5.3% |
| -2250.9% |